Chinese contentFDA拨款129万美元给Cognita Imaging，用LLM作为陪审团评估百万级放射报告
FDA给Cognita Imaging拨款，他们要验证用LLM作为陪审团来评估百万级放射报告，挺有意思的。
USGrantIn forceModel providersDeployers
FDA Awards Cognita Imaging $1.29M to Validate LLM-as-a-Jury Evaluation Across 1 Million Radiology Reports
美国FDA向Cognita Imaging拨款129万美元用于LLM作为陪审团评估百万级放射报告
FDA·Published 2026-09-16·Checked by 管理员 on 2026-09-18
The U.S. Food and Drug Administration (FDA) awarded Cognita Imaging, Inc. (a wholly owned subsidiary of Mosaic Clinical Technologies, Inc.) a $1.29 million research contract to pioneer new methodologies for evaluating autonomous, generative AI radiology reports. The 18-month contract, effective June 22, aims to validate the LLM-as-a-Jury evaluation method across 1 million radiology reports.
What it means for you
• Company Obligations: Cognita Imaging must complete the development and validation of an LLM-as-a-Jury evaluation method for 1 million radiology reports within 18 months, meeting FDA research requirements.
What to do
ComplianceMonitor the FDA's research progress on AI radiology report evaluation standards and assess its impact on existing products.
ProductEvaluate the LLM-as-a-Jury technical solution and explore its potential applications in radiology report quality control and efficiency improvement.
Key dates
2026-06-22In force
2026-09-16Published
Source documents
Coverage
Stories in the feedEditorial summary, not legal advice; dates and status follow the original document. · Report a correction